Nanooptogenetic immunotherapy for b cell lymphoma
Ended Project Grant Awarded Last action
- Award ID
- R01CA232017
- Recipient
-
University Of Massachusetts Medical School UEI MQE2JHHJW9Q8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,480,877
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Funding
-
- $3,043,184.00 Federal
- $437,693.00 Non-federal
- Place of performance
- Worcester, MA 01605, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $407,858 | $0 | |
| Amendment | $418,557 | $0 | |
| Amendment | $418,557 | $0 | |
| Amendment | $437,693 | $0 | |
| Amendment | $437,693 | $437,693 | |
| Amendment | $447,986 | $0 | |
| Original award | $474,840 | $0 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Texas A & M University System Health Science Center Research | $192,762 |
Quick answers
Who received award R01CA232017?
R01CA232017 was awarded to University Of Massachusetts Medical School by National Cancer Institute (National Institutes of Health) on May 1, 2019.
How much is award R01CA232017 worth?
$3,480,877 has been obligated on R01CA232017: $3,043,184 in federal funding and $437,693 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award